Document Detail


Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases.
MedLine Citation:
PMID:  3312046     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Sobrerol is an agent with a terpenic structure used to modify mucus characteristics in patients with hypersecretory bronchopulmonary diseases and this review is aimed at listing and discussing all the scientific evidence on this drug. All the toxicological findings testify its excellent tolerability and very low toxicity. In the pharmacological section of the review the effects of sobrerol on mucus production and its characteristics are discussed together with its effect on experimental models. A number of open clinical trials suggesting a therapeutic potential activity of the drug is examined together with a series of randomized double-blind clinical trials confirming its efficacy in relieving obstructive symptoms in chronic bronchitic patients.
Authors:
P C Braga; L Allegra; R Bossi; R Scuri; C L Castiglioni; S Romandini
Related Documents :
22304736 - Effects of reminiscence interventions on psychosocial outcomes: a meta-analysis.
19158446 - Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting th...
21221026 - Prevention of ventriculostomy-related infections with prophylactic antibiotics and anti...
22863996 - Validation of a detailed scoring checklist for use during advanced cardiac life support...
17963846 - Patterns of response to repetitive transcranial magnetic stimulation (rtms) in major de...
10363736 - Loracarbef versus clarithromycin in children with acute otitis media with effusion.
Publication Detail:
Type:  Clinical Trial; Journal Article; Review    
Journal Detail:
Title:  International journal of clinical pharmacology research     Volume:  7     ISSN:  0251-1649     ISO Abbreviation:  Int J Clin Pharmacol Res     Publication Date:  1987  
Date Detail:
Created Date:  1987-12-04     Completed Date:  1987-12-04     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8110183     Medline TA:  Int J Clin Pharmacol Res     Country:  SWITZERLAND    
Other Details:
Languages:  eng     Pagination:  381-400     Citation Subset:  IM    
Affiliation:
Department of Pharmacology, Chemotherapy and Toxicology, University of Milan, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Bronchitis / drug therapy*
Bronchoalveolar Lavage Fluid / analysis
Clinical Trials as Topic
Expectorants / pharmacology,  therapeutic use*
Humans
Mucociliary Clearance / drug effects
Mucus / drug effects*
Terpenes / pharmacology,  therapeutic use*
Viscosity
Chemical
Reg. No./Substance:
0/Expectorants; 0/Terpenes; 498-71-5/sobrerol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Changes in the broncho-alveolar lavage fluid in smokers and patients with chronic obstructive lung d...
Next Document:  FFA and insulin response dissociation to gradual short-term food restriction in exercising rats.